| 1. long-term outcome and prognostic factors of nasopharyngeal carcinoma treated by intensity modulated radiotherapy |
Page:488—491 |
| 2. Comparative study of gross tumor volume shown on MRI and FDG PET/CT of nasopharyngeal carcinoma |
Page:492—495 |
| 3. Prognostic analysis of brain metastases from primary breast cancer treated with stereotactic radiotherapy |
Page:496—499 |
| 4. A prospective phase Ⅰ / Ⅱ study of recombinant endostatin (Endostar) combined with concurrent radio-chemotherapy in patients with unresectable stage Ⅲ non-small cell lung cancer |
Page:500—503 |
| 5. The study on importance of three-dimensional radiotherapy for elderly patients with stage Ⅳ non small cell lung cancer |
Page:504—507 |
| 6. Analysis of GTV artifacts in each phase of four dimensional CT for peripheral lung cancer based on three dimensional CT assisted with active breathing control |
Page:508—512 |
| 7. Analysis of treatment outcome for stage Ⅲ thymoma |
Page:513—517 |
| 8. Clinical study of cetuximab combined with concurrent chemoradiotherapy for esophageal squamous cell carcinoma |
Page:518—521 |
| 9. Clinical research of extensive regional field radiotherapy concurrent with chemotherapy for locally advanced esophageal cancer |
Page:522—525 |
| 10. Clinical outcome of early stage breast cancer treated with short-course radiotherapy with concomitant tumor bed boost after breast conserving surgery |
Page:526—529 |
| 11. Meta-analysis of radiotherapy on triple-negative breast cancer after breast conservation surgery |
Page:531—533 |
| 12. The influence of delineating criteria training on the delineation of tumor bed and whole breast target after breast-conserving surgery |
Page:534—538 |
| 13. Comparison of prognostic factors and outcome of patients with advanced cervical cancer between Han and Uygur in Xinjiang district |
Page:540—542 |
| 14. Dosimetric study of volumetric intensity-modulated arc therapy and fixed field intensity-modulated radiotherapy for cervix cancer |
Page:543—546 |
| 15. The study of two-dimensional dosimetric verifications of volumetric intensity-modulated arc therapy based on electronic portal imaging devices |
Page:550—553 |
| 16. Simulation of respiratory motion effect on dose distributions in three-dimensional radiotherapy |
Page:554—556 |
| 17. Measurement and calculation of X-ray small fields' data for Varian accelerator |
Page:557—559 |
| 18. A daily quality assure procedure for the on board imager and analysis of the results |
Page:560—562 |
| 19. Optimizing the schedules of fractionated irradiation in subclinical tumors of malignant glioma |
Page:563—566 |
| 20. Radiosensitizing effect of cisplatin on CNE-1 xenograft in nude mice |
Page:567—570 |
| 21. The radiosensitizing effect of nano-gold and nano-silver particles in HepG2 hepatocellular carcinoma cell |
Page:571—574 |
| 22. The study of mechanical movement displacement for three amorphous silicon electronic portal imaging devices |
Page:76—79 |
| 23. Initial clinic verification of internal target volume generated with four-dimensional CT and deformable registration |
Page:80—83 |
| 24. Analysis of relationship between protein expression of XRCC3 and HOGG1 and prognosis in patients with esophageal squamous cell carcinoma after radiotherapy |
Page:108—110 |
| 25. Value of local progression-free survival for evaluating local outcome of peripheral lung cancer treated by cyberknife |
Page:115—117 |
| 26. The application of equivalent uniform dose in planning optimization of intensity-modulated radiotherapy for prostate cancer |
Page:143—146 |
| 27. Phase Ⅰ / Ⅱ clinical trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by intensity-modulated radiotherapy and concomitant chemotherapy in locally advanced nasopharyngeal carcinoma |
Page:129—132 |
| 28. Evaluating short-term radiotherapeutic effect on esophageal cancer by barium meal combined with CT scans |
Page:26—29 |
| 29. Analysis of late toxicities after intensity-modulated radiotherapy in 176 patients with nasopharyngeal carcinoma |
Page:42—45 |
| 30. Therapeutic effect of concurrent chemotherapy and intensity-modulated radiotherapy following induction chemotherapy in patients with locally advanced nasopharyngeal carcinoma |
Page:47—51 |
| 31. Effect of RNA interference of STAT1 expression on radiosensitivity and cell cycle of esophageal carcinoma cell line Eca109 |
Page:53—57 |
| 32. Analysis of number of fiducial and infective factors for tracking tumor with stereotactic body radiation therapy |
Page:58—60 |
| 33. Measurements of the peripheral dose from megavoltage cone-beam CT imaging for head-and-neck region image-guided radiation therapy |
Page:151—153 |
| 34. Changes in abilities of invasion and metastasis in surviving human lung adenocarcinoma (A549) cells after X-ray irradiation and related mechanism |
Page:163—166 |
| 35. Incidental nodal irradiation with involved-field conformal radiotherapy for patients with thoracic esophageal squamous cell carcinoma |
Page:30—34 |
| 36. Impacts of different tracking methods on short-term therapeutic effect of cyberknife in treatment of lung cancer |
Page:36—38 |
| 37. Off-line analysis of gross tumor volume changes in nonoperatively treated lung cancer patients during radiotherapy by kilovoltage cone-beam computed tomography |
Page:39—41 |
| 38. Study on accurateness of percentage depth dose with Monte Carlo simulation algorithm |
Page:64—67 |
| 39. Predictive value of molecular subtyping for loco-regional recurrence in early breast cancer patients with one to three positive axillary lymph nodes |
Page:89—93 |
| 40. Diagnostic value of serum VEGF level for advanced cervical cancer and its relationship with therapeutic efficacy of concurrent chemoradiotherapy |
Page:99—101 |
| 41. Value of 18 F-FDG PET-CT in predicting long-term response to three-dimensional radiotherapy in patients with esophageal squamous cell carcinoma |
Page:123—127 |
| 42. Volume of prophylactic irradiation to neck for stage N0 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy |
Page:133—137 |
| 43. Evaluation of extra absorbed dose generated by image guided system of the Cyberknife |
Page:154—156 |
| 44. Dosimetric effect of multi-leaf collimator transmission on intensity-modulated radiation therapy |
Page:157—160 |
| 45. Prognostic analysis of 130 patients with nasal and Waldeyer ring NK/T cell lymphoma treated by radiotherapy and/or chemotherapy |
Page:180—184 |
| 46. Study on clinical typing of nasopharyngeal carcinoma in patients treated by intensity-modulated radiotherapy |
Page:217—219 |
| 47. A comparative study of intensity-modulated radiotherapy with concurrent PF or TP chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma |
Page:230—233 |
| 48. Validation of MRI-or CT-based gross tumor volume delineation in head and neck cancer: a comparative study |
Page:234—236 |
| 49. Practical value of low-dose CT scanning in simulated location of lung cancer |
Page:237—238 |
| 50. Analysis of therapeutic effects of radiochemotherapy and chemotherapy alone in patients with advanced gastric cancer after gastrectomy |
Page:263—265 |
| 51. Implement of the radiation therapy case study multi-media system based on windows remote desktop feature |
Page:322—324 |
| 52. Long-term outcomes of patients with advanced N-stage nasopharyngeal carcinoma treated by intensity-modulated radiotherapy alone or with chemotherapy |
Page:225—229 |
| 53. Study of the feasibility and precision in dose calculation with the method of bulk density assignment |
Page:247—249 |
| 54. Comparison of pencil beam convolution and anisotropic analytical algorithm for intensity-modulated radiotherapy planning of lung cancer |
Page:250—252 |
| 55. The characteristics and clinical application of the ArcCHECK diode array for volumetric-modulated arc therapy verification |
Page:253—257 |
| 56. Long-term outcomes of patients with nasopharyngeal carcinoma in different stages treated by intensity-modulated radiotherapy and their treatment strategies |
Page:291—294 |
| 57. Prognostic impact of MRI-detected prevertebral space involvement in nasopharyngeal carcinoma |
Page:295—298 |
| 58. Prognostic impact of degree of bone metastasis in patients with nasopharyngeal carcinoma after radiochemotherapy |
Page:299—302 |
| 59. Study on multicriteria optimization of intensity-modulated radiotherapy planning comparing with direct machine parameter optimization |
Page:305—308 |
| 60. Delta three-dimensional semiconductor array verification for intensity modulated planning of helical tomotherapy |
Page:309—311 |
| 61. Analyse two kinds of intensity-modulated radiotherapy verification methods comparatively by using the MatriXX |
Page:312—314 |
| 62. The clinical effect of Body-Fix(R) device in improving the positioning accuracy of the hypofractionated radiotherapy in the vertebral metastatic patients |
Page:315—317 |
| 63. UHRF1 expression inhibition by RNA interference enhances the radiosensitivity of esophageal cancer cells |
Page:326—329 |
| 64. A study of radiosensitizing effect of PKM2 silencing in lung adenocarcinoma cells and xenografts |
Page:466—470 |
| 65. Preliminary efficacy of bevacizumab for cerebral radiation necrosis |
Page:434—437 |
| 66. Safety analysis of Intensity-modulated radiation therapy of glioblastoma with simultaneous integrated boost technique |
Page:431—433 |
| 67. Paired observation of californium-252 neutron intraluminal brachytherapy combined with external-beam radiotherapy with and without lead shielding for cervical cancer |
Page:400—403 |
| 68. A study of changes in volume and location of target areas and organs at risk in intensity-modulated radiotherapy for cervical cancer |
Page:395—399 |
| 69. Real-time patient transit dose verification of volumetric modulated arc therapy by a 2D ionization chamber array |
Page:462—465 |
| 70. Investigation of CT numbers correction of kilo-voltage cone-beam CT images for accurate dose calculation |
Page:457—461 |
| 71. The effect of the shrinkage of thermoplastic mask on patient positioning |
Page:454—456 |
| 72. The technique and development of total skin electron irradiation-Taiwan experiences |
Page:449—453 |
| 73. Comparing different image registration methods in kilovolt cone-beam computed tomography image-guided radiotherapy for liver cancer |
Page:444—448 |
| 74. The role of transoralsonography guiding fine-needle aspiration biopsy in the diagnosis of retropharyngeal or parapharyngeal masses identified on the images of treated patients with malignant carcinoma |
Page:427—430 |
| 75. Post-treatment prognostic score model establishment and stratified therapy for newly diagnosed metastatic nasopharyngeal carcinoma |
Page:421—426 |
| 76. A multicenter, prospective, randomized study of intensity-modulated radiother apy combined with different chemotherapy regimens for locally advanced nasopharyngeal carcinoma |
Page:417—420 |
| 77. A comparative study of CT-and MRI-based three-dimensional conformal brachytherapy for locally advanced cervical cancer |
Page:408—413 |
| 78. Clinical efficacy of CyberKnife radiotherapy for locally advanced pancreatic carcinoma |
Page:392—394 |
| 79. Clinical outcome and prognosis of Waldeyer’s ring diffuse large B-cell lymphoma:an analysis of 200 patients |
Page:382—386 |
| 80. Preliminary results of a phase Ⅱ prospective clinical study of early-stage nasal NK/T-cell lymphoma with extended involved-field intensity-modulated radiotherapy |
Page:377—381 |
| 81. A pathological comparative study of diffusion-weighted imaging and computed tomography in determination of lesion length for esophageal carcinoma |
Page:373—376 |
| 82. The patterns of lymph node metastasis in adenocarcinoma of esophagogastric junction:a reference for target volume delineation in radical radiotherapy |
Page:367—371 |
| 83. A prospective, multicenter, phase II clinical study of three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small-cell lung cancer-PPRA-RTOG003 |
Page:359—364 |
| 84. Impacts of endostatin on expression of vascular endothelial growth factor receptor-2 in non-small cell lung cancer cells and mechanisms underlying its radiosensitizing effect |
Page:593—597 |
| 85. Impacts of applicators on 192 Ir brachytherapy dosimetry |
Page:585—587 |
| 86. Image registration of a three-dimensional dynamic phantom in four-dimensional cone-beam computed tomography and four-dimensional computed tomography |
Page:581—584 |
| 87. Application of ExacTrac and cone-beam computed tomography image-guided radiotherapy in intensity-modulated radiotherapy for lung cancer |
Page:560—563 |
| 88. Comparison of internal tumor volume based on different reconstruction modes of 4DCT for solitary pulmonary lesion |
Page:556—559 |
| 89. An analysis of efficacy of intensity-modulated radiotherapy with concurrent chemotherapy for stage T1-2 N1 nasopharyngeal carcinoma |
Page:529—532 |
| 90. Dosimetric analysis of computed tomography guided three-dimensional intracavitray brachytherapy in endometrial carcinoma |
Page:569—572 |
| 91. Comparison of planning parameter selection for volumetric modulated arc therapy of nasopharyngeal carcinoma in two different treatment planning systems |
Page:564—568 |
| 92. Comparison of difference registration landmarks for image - guided radiotherapy for lung cancer |
Page:552—555 |
| 93. An analysis of multimodal treatment outcomes and patterns of treatment failure in esthesioneuroblastoma |
Page:534—538 |
| 94. Chemoradiotherapy for locally advanced rectal cancer:a clinical analysis of 47 patients |
Page:521—524 |
| 95. An analysis of efficacy of pelvic radiotherapy and prognostic factors for stage IV rectal cancer |
Page:516—520 |
| 96. Relationship between prostate volume reduction and neoadjuvant hormone therapy duration in prostate cancer radiotherapy |
Page:511—515 |
| 97. Prognostic value of primary tumor site in early breast cancer patients with one to three positive axillary lymph nodes after radical surgery |
Page:506—510 |
| 98. Value of radiotherapy for early-stage Waldeyer ’ s ring diffuse large B-cell lymphoma in the rituximab era |
Page:502—505 |
| 99. A comparative study of planning target volumes based on three-dimensional computed tomography, four-dimensional computed tomography, and positron emission tomography-computed tomography in thoracic esophageal cancer |
Page:497—501 |
| 100. A comparative study of computed tomography and magnetic resonance imaging in pathological diagnosis of regional lymph node metastasis |
Page:493—496 |
| 101. Comparison of efficacy of different fractionation schedules in radiotherapy for extensive-stage small cell lung cancer |
Page:488—492 |
| 102. The development and application of the radiotherapy information management system |
Page:680—683 |
| 103. A dosimetric study of hippocampal-avoidance prophylactic cranial irradiation in intensity-modulated radiotherapy and volumetric modulated arc therapy for patients with localized small cell lung cancer achieving complete response after chemoradiotherapy |
Page:675—679 |
| 104. Treatment of primary sphenoid sinus malignancies:an analysis of 16 patients |
Page:671—674 |
| 105. Movement of the hyoid bone and ventriculus laryngis in normal swallowing |
Page:668—670 |
| 106. Influence of change in anatomical volume on dose distribution during intensity-modulated radiotherapy for different stages of nasopharyngeal carcinoma |
Page:664—667 |
| 107. Long-term efficacy of intensity-modulated radiotherapy with or without chemotherapy in treatment of nasopharyngeal carcinoma and its influencing factors:an analysis of 454 patients |
Page:659—662 |
| 108. Comparison between the 7th edition of International Union Against Cancer staging system and the Chinese 2008 staging system for nasopharyngeal carcinoma and suggestions for the updating of the staging system |
Page:653—658 |
| 109. Correlation between the dose measured in the rectum and reference dose in three-dimensional brachytherapy for cervical cancer |
Page:649—652 |
| 110. Effects of bladder and rectum management on dose distributions of target and organs at risk in intensity-modulated radiotherapy for prostate cancer |
Page:644—648 |
| 111. Comparison of static intensity-modulated radiation therapy and volumetric modulated arc therapy in early-stage primary mediastinal B-cell lymphoma |
Page:638—643 |
| 112. Analysis of efficacy and prognostic factors of postoperative intensity-modulated radiotherapy with or without chemotherapy in rectal cancer |
Page:633—637 |
| 113. Predictors of pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer |
Page:627—632 |
| 114. Optimization of radiotherapy target delineation after breast cancer surgery |
Page:623—626 |
| 115. A prospective phase II study of consolidation chemotherapy after concurrent chemoradiotherapy for oligometastatic stage IV non-small cell lung cancer |
Page:611—614 |
| 116. Predictive factors for acute symptomatic esophagitis in 256 patients with locally advanced non-small cell lung cancer treated with intensity-modulated radiation therapy |
Page:605—610 |
| 117. Effects of RNA interference-mediated silencing of vascular endothelial growth factor receptor-2 on proliferation, migration, invasion, and radiation-induced effects in Calu-1 cells |
Page:714—718 |
| 118. Radiotherapy following modified radical mastectomy significantly improves locoregional control in patients with Rec-/HER-2+ locally advanced breast cancer |
Page:619—622 |
| 119. A comparative study of different irradiation ranges in radical radiotherapy for early-stage esophageal cancer |
Page:615—618 |
| 120. Effect of RNA interference for MDC1 gene on cell cycle and expression of related proteins in esophageal carcinoma cells after X-ray radiation |
Page:708—713 |
| 121. Establishment and biological characterization of radiation-resistant lung carcinoma cell lines |
Page:703—707 |
| 122. Physical characteristics research of OPEN stereotactic body gamma knife |
Page:699—702 |
| 123. DVH Obejective informed Planning in volume modulated arc therapy |
Page:695—698 |
| 124. Research on the geometric difference between different ITV generation methods in non-small cell lung cancer treated with stereotactic radiotherapy |
Page:688—692 |
| 125. Value of nutritional risk screening-2002 in evaluating nutritional status of patients with esophageal cancer undergoing radiotherapy |
Page:234—238 |
| 126. Clinical efficacy of preoperative three-dimensional radiotherapy with or without concurrent chemotherapy for esophageal carcinoma |
Page:220—226 |
| 127. The effect of brain metastases from NSCLC and treatment targeted plus radiotherapy on EGFR mutations |
Page:296—300 |
| 128. Research progress of axillary management approach for 1-2 sentinel lymph node positive early stage breast cancer patients |
Page:292—295 |
| 129. The application of PET/CT to predict prognosis of radiotherapy of NSCLC |
Page:288—291 |
| 130. Verification and calibration of leaf position of a multi-leaf collimator by ionization chamber arrays |
Page:279—281 |
| 131. Imaging dose and risk of Varian thoracic cone beam CT to the ICRP computational reference phantom |
Page:275—278 |
| 132. Establishment of quality control evaluation system for 3D-ultrasound-based image-guided radiotherapy |
Page:270—274 |
| 133. Analyzing of correlation between the setup error and the couch position in radiotherapy |
Page:266—269 |
| 134. Commissioning of Axesse accelerator for volumetric modulated arc therapy |
Page:260—265 |
| 135. A dosimetric comparison of static intensity-modulated radiotherapy, volumetric-modulated arc therapy,and helical tomotherapy after surgery for gastroesophageal junction adenocarcinoma |
Page:255—259 |
| 136. Image registration and target volume margins in cone-beam computed tomography-guided intensity-modulated radiotherapy for prostate cancer |
Page:249—254 |
| 137. Effect of MRI-guided intensity-modulated radiotherapy with bone marrow protection on hematologic toxicity in patients with rectal cancer undergoing concurrent chemoradiotherapy |
Page:244—248 |
| 138. Clinical value of induction chemotherapy plus concurrent radiochemotherapy for locally advanced non-small cell lung cancer:a Meta analysis |
Page:239—243 |
| 139. Association of local factors with treatment failure patterns in esophageal squamous cell carcinoma without clinical metastasis |
Page:228—233 |
| 140. Treatment outcomes of primary suprasellar and pineal germinoma and related therapeutic strategies:an analysis of 41 patients |
Page:216—219 |
| 141. Failure in region of parotid gland after definitive intensity-modulated radiotherapy for Nasopharyngeal Carcinoma |
Page:212—215 |
| 142. Prognostic values of 18 F-FDG PET/CT parameters in patients with nasopharyngeal carcinoma |
Page:207—211 |
| 143. A brief history of Macau radiotherapy development |
Page:195—196 |
| 144. The research of IMRT plan optimization on dose limitation of sub regional auditory organ |
Page:438—441,442 |
